To investigate differences in neutrophil subpopulations between individuals with multiple sclerosis (MS) and healthy controls, highlighting the significance of these differences in understanding MS pathology.
Key Findings:
CD10low neutrophils were significantly enriched in the blood of individuals with CIS and MS compared to controls.
CD10low neutrophils exhibited decreased CD16 and CD11b expression, indicating an immature phenotype, which may affect their functional roles.
Proportions of CD10low neutrophils in MS patients were non-significantly correlated with expanded disability status scores (p=0.06).
Interpretation:
The presence of immature CD10low neutrophils in MS suggests a potential role in the disease's pathology and warrants further investigation into their functions as biomarkers, potentially influencing future therapeutic strategies.
Limitations:
Small sample size of 22 participants limits generalizability and may introduce selection bias.
Non-significant correlation with disability scores may require larger studies for validation.
Conclusion:
Immature CD10low neutrophils may play a significant role in active MS disease, highlighting the need for further research into their functions and implications in MS pathology, which could inform treatment approaches.
by Luke W. Garratt, Alice A. White, Craig Schofield, Jonatan Leffler, Prue H. Hart, Marzena J. Fabis-Pedrini, Allan G. Kermode, Anne Brüstle, Stephanie Trend
